Navigation Links
Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down

New research shows that a form of vitamin A used to treat acute promyelocytic leukemia induces changes in an unusual class of small molecules called microRNAs (miRNAs) in the// leukemic cells.

The study also shows that three of these miRNAs inhibit the action of two genes important for cancer development, helping to explain how the drug works.

The drug is called all-trans-retinoic acid (ATRA) and it is considered the gold standard for treating the disease.

The study showed that ATRA raises the levels of three particular miRNAs in leukemia cells and that this rise coincides with a fall in activity of two important cancer-causing genes. The three are identified as miRNA-15b, miRNA-16-1 and let-7.

Two of these, miRNA-15b and miRNA-16-1, reduce the activity of the Bcl-2 gene, which is over-active in many kinds of cancer. The protein produced by this gene blocks the normal process of cell death and helps keep cancer cells alive long after they should have died.

The remaining miRNA molecule, let-7, lowered the activity of the Ras oncogene, an important cancer-causing gene. (Oncogenes are normal genes that when mutated lead to cancer.)

Researchers at the Ohio State University Comprehensive Cancer Center led the study, which was published in a recent issue of the journal Oncogene.

“The findings are important because they tell us that some miRNAs switch off genes that promote cancer,” says first author Ramiro Garzon, a hematologist and oncologist at Ohio State's James Cancer Hospital and Solove Research Institute.

Acute promyelocytic leukemia occurs when cells that give rise to a form of white blood cell become stuck at an immature stage. The immature cells accumulate until they crowd out healthy white cells in the blood and bone marrow.

“Our findings suggest that these three miRNAs help re-program the malignant cells to a more normal state,” Garzon says, “and
'"/>




Page: 1 2

Related medicine news :

1. Cyclosporin A Treats Leukemia Complications
2. Leukemia pill shows promise against stomach cancer
3. Aspirin Lowers Leukemia Risk
4. Hope for Chemo-Resistant Leukemia Patients
5. Genes Found To Help Leukemia Treatment
6. Looking Towards More Effective Leukemia Treatment
7. Diet Found To Offer Protection Against Leukemia
8. Exposure To Night Light may Increase The Risk Of Leukemia
9. Skin Allergies Found To Increase The Risk Of Leukemia
10. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
11. Night Light Found To Increase The Risk Of Leukemia
Post Your Comments:
(Date:10/8/2008)...n & Laser Center is well established as a tech...w York City. The facility is living up to its repu... skin resurfacing treatments to receive FDA approv..., New York, NY (PRWEB) Oct...atment industry is in the midst of an unprecedente...
(Date:10/7/2008)...elated Questions for Tonight,s,Presidential Debate...D, the leading source of,health information, today...ndidates, proposed health care policies, located a...candidates, stance on health insurance, medical an...c health issues., The in-depth coverage is just o...
(Date:10/7/2008)...Newswire-USNewswire/ -- IPRO, one of the,nation,s ...ations, has,created a Limited Liability Company (L...t oversight and consulting contracts with managed ...l (http://www.logiqual.com ), is now,officially i...w.newscom.com/cgi-bin/prnh/20081007/DC37283LOGO-a ...
(Date:10/7/2008)...-USNewswire/ -- As the presidential,candidates com...ate, Jean,Berg, a nursing assistant and member of ...waiting to ask John McCain why he wants to tax hea...o afford coverage., Berg has been a nursing assis...are., "It,s the single biggest economic factor in...
Breaking Medicine News(10 mins):Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:IPRO Spins Off Managed Care Review Affiliate 2Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2
...eading player in the Indian drug industry, has rec...Authority (FDA) for three// of its abbreviated new...d will be launching this product in the US through...potex, the Chennai-based company said in a release...
...eople suffering from osteoporosis are not told abo...cording to the research by the University of Weste...alians being affected by osteoporosis, the problem...ly. Dr Charles Inderjeeth from the School of Popu...
...rimination against HIV/AIDS victims will be tabled...or approval.// In the light of the XVI Internatio...i Ramadoss said, "it took a little time, because w...d elaborate discussions with the stakeholders. Hop...
...ed yesterday that a Walkers crisps advertising cam...ntent.// According to the industry watchdog a pro...salt in its crisps to "7% of your guideline daily ...act that the reduction did not apply to all Walker...
Other Medicine News:Health News:Negligence in Osteoporosis treatment 2Health News:Legislation to Prevent Discrimination against HIV/AIDS Victims 2
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A...examining embryonic stem cell self-renewal,report...lastim (recombinant,human serum albumin) was an ef...cell culture., The article entitled, "The ground ...sed that researchers used Cellastim as a recombina...
(Date:10/7/2008)... CAMBRIDGE, Mass., Oct. 7 /- Tali... data on several of the Company,s pipeline,candida...ement Workshop in,Basel, Switzerland. The data hig...l models of complement-mediated diseases., "These...vitro studies,presented at the conference, reveal ...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long-...n,s disease patients presented at American College.../- Data from two studies,pr...f Gastroenterology,(ACG) Annual Meeting demonstrat...EGylated anti-TNF alpha (Tumor Necrosis Factor alp...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- A...today that a poster entitled "RDEA119, a Potent,an...in Dextran Sulfate,Sodium (DSS) -- induced Chronic...ollege of Gastroenterology (ACG) 2008 Annual Meeti... data from a preclinical study of,RDEA119, the Com...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4The story of Max Perutz a pioneering biologist with a remarkable passion for life 2832 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
The Smith & Nephew ECTRA II systems permit the surgeon to access and release the carpal tunnel ligament endoscopically, allowing access via two portals for distal and proximal cutting, while minimizi
The Stryker AZTEC Shoulder Holder is used for positioning the patients arm during surgery in the lateral position. The shoulder holder is adjustable with respect to height and rotation for all arm po
Medicine Products: